Recent Publications
Kelly WN,
Arellano FM, Barnes J, Bergman U, Edwards IR, Fernandez SB,
Goldsmith DI, Huang KA, Jones JK, McLeay R, Moore N, Stather RH,
Trenque T, Troutman WG, van Puijenbroek E, Williams F, and Wise RP.
Guidelines for submitting adverse event reports for publication.
Drug Safety. 2007;30(5):367-373.
Kelly WN,
Arellano FM, Barnes J, Bergman U, Edwards IR, Fernandez SB,
Goldsmith DI, Huang KA, Jones JK, McLeay R, Moore N, Stather RH,
Trenque T, Troutman WG, van Puijenbroek E, Williams F, and Wise RP.
Guidelines for submitting adverse event reports for publication.
Pharmacoepidemiology and Drug Safety. 2007;16:581-587.
Kelly WN. Pharmacy: What It Is and How
It Works. CRC Publishing Company, Boca Raton, Florida. 2nd Edition,
2002, 2007.
Kelly WN. Prescribed Medication
and the Public Health: Laying the Foundation for Risk Reduction.
Haworth Press, Binghamton, NY. 2006.
Kelly WN.
Compelling Features of a Safe Medication Use System. American Journal of Health-System
Pharmacists. 2006;63:1461-6
Kelly WN.
The Role of Pharmacoepidemiology in Drug Injury and Expert
Testimony. Chapter 11 in Drug Injury: Liability, Analysis and
Prevention. Second Edition. Edited by James T. O’Donnell. Lawyers
and Judges Publishing Company. Tucson, AZ. 2005.
Al-Tajir G
and Kelly WN. The Epidemiology, Methods of
Detecting, and
Preventing of Adverse Drug Events at Al Qassimi Hospital.
Annals of
Pharmacotherapy. 2005;39:1169-1174.
Kelly WN.
Medication Errors: Lessons Learned and Actions
Needed.
Professional Safety. 2004;49(7):35-41.
Voiles KM and Kelly WN.
Potential Interactions Between Oral Contraceptives and Other
Medications and Natural Substances.
U.S. Pharmacist.
2004;29(1).
Steele DR and Kelly WN.
Documenting Errors Benefits Patients, Pharmacies. Drug
Topics. 2004:January 26;66, 71.
Housley S, and Kelly WN.
Drug Interaction Monitoring: Good, Bad, and Ugly. Drug Topics.
2003:September 1; 41-42.
Kelly WN. The quality of published adverse drug event reports.
Annals of Pharmacotherapy. 2003;37(12):1774-1778.